Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Laboratories Inc
Original Assignee
Bristol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Laboratories IncfiledCriticalBristol Laboratories Inc
Publication of ES218995A1publicationCriticalpatent/ES218995A1/en
Procedure for preparing a therapeutic composition characterized in that a member selected from the group consisting of the tetracycline free base is mixed with the non-toxic metallic and acid addition salts of the itself and at least one additional drug. (Machine-translation by Google Translate, not legally binding)
ES0218995A1953-12-171954-12-14A procedure for preparing a therapeutic composition (Machine-translation by Google Translate, not legally binding)
ExpiredES218995A1
(en)
A procedure for the preparation of solutions of the polycondensates of acid amidas alquiliden and aralquiliden-bis-tiocarboxºlicos (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of 3; 17-dioles of the ciclopentanopolihidrofenantreno series (Machine-translation by Google Translate, not legally binding)
Procedure for the preparation of a new derivative of pirazolidine-hexametilenimina with therapeutic properties. (Machine-translation by Google Translate, not legally binding)